dilazep has been researched along with Shock, Septic in 1 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
Shock, Septic: Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ronconi, P | 1 |
| Borzone, A | 1 |
| Nanni, G | 1 |
| Bonatti, PL | 1 |
| Pittiruti, M | 1 |
1 other study available for dilazep and Shock, Septic
| Article | Year |
|---|---|
[Use of dilazep to prevent peripheral, systemic and regional hemodynamic changes in the course of endotoxic shock].
Topics: Animals; Azepines; Dilazep; Rabbits; Shock, Septic | 1980 |